Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S1PR2 | O95136 | 1/20 | 0.52 |
| ▸ | S1PR1 | P21453 | 1/20 | 0.52 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.52 |
| ▸ | S1PR5 | Q9H228 | 1/20 | 0.52 |
| ▸ | GGPS1 | O95749 | 4/20 | 0.44 |
| ▸ | KDM4C | Q9H3R0 | 6/20 | 0.44 |
| ▸ | KDM5A | P29375 | 5/20 | 0.44 |
| ▸ | PHF8 | Q9UPP1 | 2/20 | 0.44 |
| ▸ | FDPS | P14324 | 1/20 | 0.43 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.43 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.43 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.43 |
| ▸ | DNM1 | Q05193 | 3/20 | 0.43 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
| ▸ | KDM5C | P41229 | 1/20 | 0.41 |
| ▸ | KDM5B | Q9UGL1 | 1/20 | 0.41 |
| ▸ | KDM4A | O75164 | 2/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28875752 | 1.00 | S1PR2 (0.52) | S1PR2S1PR1S1PR3S1PR5GGPS1 | |
| SCHEMBL20495919 | 1.00 | S1PR2 (0.52) | S1PR2S1PR1S1PR3S1PR5GGPS1 | |
| SCHEMBL26125775 | 1.00 | S1PR2 (0.52) | S1PR2S1PR1S1PR3S1PR5GGPS1 | |
| SCHEMBL5430321 | 1.00 | S1PR2 (0.52) | S1PR2S1PR1S1PR3S1PR5GGPS1 | |
| SCHEMBL2925349 | 1.00 | S1PR2 (0.52) | S1PR2S1PR1S1PR3S1PR5GGPS1 | |
| SCHEMBL22861284 | 1.00 | S1PR2 (0.52) | S1PR2S1PR1S1PR3S1PR5GGPS1 | |
| SCHEMBL625083 | 0.98 | S1PR2 (0.50) | S1PR2S1PR1S1PR3S1PR5GGPS1 | |
| SCHEMBL31490360 | 0.98 | S1PR2 (0.50) | S1PR2S1PR1S1PR3S1PR5GGPS1 | |
| SCHEMBL6900475 | 0.98 | S1PR2 (0.50) | S1PR2S1PR1S1PR3S1PR5GGPS1 | |
| SCHEMBL31286091 | 0.98 | S1PR2 (0.50) | S1PR2S1PR1S1PR3S1PR5GGPS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250213443-A1 | CLEANSING AGENT | SHISEIDO COMPANY, LTD. (JP) | 2025-07-03 | — | — | US | disclosed |
| EP-3610868-B1 | AMINO- OR AMMONIUM-CONTAINING SULFONIC ACID DERIVATIVES AND THEIR MEDICAL USE | GRI BIO INC (US) | 2025-02-19 | — | — | EP | disclosed |
| WO-2024247734-A1 | OIL-IN-WATER TYPE COSMETIC | 株式会社 資生堂 | 2024-12-05 | — | — | WO | disclosed |
| CN-109195574-B | Oral composition | 花王株式会社 | 2021-07-23 | — | — | CN | disclosed |
| WO-2021125174-A1 | OIL-IN-WATER TYPE EMULSION COSMETIC FOR SKIN CARE USING ELECTROPHORESIS | 株式会社 資生堂 | 2021-06-24 | — | — | WO | disclosed |
| EP-3466400-B1 | COMPOSITION FOR ORAL CAVITY | KAO CORP (JP) | 2021-03-31 | — | — | EP | disclosed |
| CN-108289823-B | Oral composition | 花王株式会社 | 2021-02-26 | — | — | CN | disclosed |
| EP-3229811-B1 | PREVENTION AND TREATMENT OF INFLAMMATORY CONDITIONS | GRI BIO INC (US) | 2021-02-24 | — | — | EP | disclosed |
| US-10829506-B2 | Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use | GRI BIO, INC. (US) | 2020-11-10 | — | — | US | disclosed |
| EP-3375432-B1 | ORAL CAVITY COMPOSITION | KAO CORP (JP) | 2020-10-21 | — | — | EP | disclosed |
| CN-108289823-A | Composition for oral cavity | 花王株式会社 | 2018-07-17 | — | — | CN | disclosed |
| US-9850265-B2 | Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use | GRI BIO, INC. (US) | 2017-12-26 | — | — | US | disclosed |
| US-9850265-B2 | Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use | GRI BIO, INC. (US) | 2017-12-26 | — | — | US | disclosed |
| US-20160016981-A1 | AMINO- OR AMMONIUM-CONTAINING SULFONIC ACID, PHOSPHONIC ACID AND CARBOXYLIC ACID DERIVATIVES AND THEIR MEDICAL USE | GLYCOREGIMMUNE, INC. (US) | 2016-01-21 | — | — | US | disclosed |
| US-20160016981-A1 | AMINO- OR AMMONIUM-CONTAINING SULFONIC ACID, PHOSPHONIC ACID AND CARBOXYLIC ACID DERIVATIVES AND THEIR MEDICAL USE | GLYCOREGIMMUNE, INC. (US) | 2016-01-21 | — | — | US | disclosed |
| EP-2809318-A1 | AMINO- OR AMMONIUM-CONTAINING SULFONIC ACID, PHOSPHONIC ACID AND CARBOXYLIC ACID DERIVATIVES AND THEIR MEDICAL USE | Jado Technologies GmbH (DE) | 2014-12-10 | — | — | EP | disclosed |
| WO-2012160187-A1 | AMINO- OR AMMONIUM-CONTAINING SULFONIC ACID, PHOSPHONIC ACID AND CARBOXYLIC ACID DERIVATIVES AND THEIR MEDICAL USE | JADO TECHNOLOGIES GMBH (DE) | 2012-11-29 | — | — | WO | disclosed |
| EP-0763355-B1 | HAIR TREATMENT COMPOSITION TO BE MIXED JUST BEFORE USE | SHISEIDO CO LTD (JP) | 2003-10-15 | — | — | EP | disclosed |
| US-5785961-A | Mixing-at the time of use-type hair-treating composition | SHISEIDO COMPANY, LTD. (JP) | 1998-07-28 | — | — | US | disclosed |
| EP-0763355-A1 | HAIR TREATMENT COMPOSITION TO BE MIXED JUST BEFORE USE | SHISEIDO COMPANY LIMITED (JP) | 1997-03-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10829506-B2 | Amino- or ammonium-containing sulfonic acid, phosphonic acid and carboxylic acid derivatives and their medical use | AADAT, AASDHPPT, ASS1 | S1PR2 1691/4885S1PR1 1737/4885S1PR3 2220/4885 |
| US-20160016981-A1 | AMINO- OR AMMONIUM-CONTAINING SULFONIC ACID, PHOSPHONIC ACID AND CARBOXYLIC ACID DERIVATIVES AND THEIR MEDICAL USE | AADAT, AASDHPPT, ASS1 | S1PR2 1701/4885S1PR1 1696/4885S1PR3 2169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.